Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Sees Large Increase in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) saw a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 30,112 shares, a growth of 4,554.1% from the October 15th total of 647 shares. Based on an average daily volume of 125,394 shares, the short-interest ratio is currently 0.2 days.

Ono Pharmaceutical Trading Down 1.2%

OPHLY traded down $0.06 on Tuesday, hitting $5.06. 41,051 shares of the stock traded hands, compared to its average volume of 38,511. Ono Pharmaceutical has a 52 week low of $4.17 and a 52 week high of $5.75. The business has a fifty day moving average price of $5.02 and a two-hundred day moving average price of $5.03.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses on areas including oncology, immunology, neurology and other serious diseases, with an emphasis on discovering therapies that address unmet medical needs. Ono is best known for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb. Opdivo is used in multiple cancer indications, depending on regulatory approval in individual markets.